ReviewClinical, cosmetic and investigational dermatology2025
Dermatofibroma: Reappraisal and Updated Review.
Review in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterization of dermatofibromas and epidermoid cysts using dermoscopy-guided high-frequency ultrasound imaging.Journal of ultrasound · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatofibromas (DF), also known as fibrous histiocytomas, are common benign cutaneous lesions characterized histologically by dermal proliferation of spindle-shaped fibrocytes, with the overlying epidermis often demonstrating hyperplasia with acanthosis, basal layer hyperpigmentation, and a characteristic "collarette" of epidermal hyperplasia surrounding the lesion. The etiology of DF remains debated, with theories ranging from reactive processes triggered by local trauma, such as insect bites, to spontaneous development. DF typically presents as a hyperkeratotic nodule or plaque, most often on the lower extremities, and can exhibit a wide spectrum of clinical appearances. Variants such as hemosiderotic, epithelioid, aneurysmal, and cellular DF show distinct clinical and histopathological features that may sometimes mimic malignant lesions. Dermoscopic findings can aid in diagnosis, although biopsy is often required for definitive classification. Discrepancies in the literature persist regarding the pathogenesis and classification of DF, and while DF is generally benign, rare cases of metastasizing DF have been reported. This review aims to provide an examination of DF, including its clinical manifestations, etiology, subtypes, histological features, and differential diagnoses. It also discusses dermoscopic findings, controversies in the literature, and current treatment options. A clearer understanding of its diverse presentations, along with refined diagnostic criteria, will enhance clinical management and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.